Logo Image
News
Watch
Expert ConversationsShows & PodcastsNews & Analysis
Conferences
Conference CoverageConference Listing
Publications
Contemporary OB/GYN® JournalDigital Supplements
More
CME/CE
Resources
Physician Fact SheetsInteractive ToolsSponsored MediaSponsored ResourcesSupplements and Featured Publications
About
Partnerships

Subscribe

  • News
  • Watch
  • Conferences
  • Publications
  • CME/CE
  • Resources
  • Subscribe
  • About
  • Partnerships
  • Breast Health
  • COVID-19
  • Cervical Health
  • Contraception
  • Curbside Consults
  • Dermatology
  • Drug Pipeline News
  • Endometriosis
  • Genetic Testing
  • Gynecology
    • Gynecologic Oncology
  • Imaging
    • Fetal Imaging
    • Abnormal Obstetrical Ultrasound
    • MRI
    • Ultrasound
    • Women's Imaging
    • Breast Imaging
    • Women's Ultrasound
  • Infertility
  • LARC
  • Legally Speaking
  • Life Transitions
  • Malpractice
  • Menopause
  • Mental Health
  • Noninvasive Prenatal Testing
  • Obstetrics
  • Opinion
  • Osteoporosis
  • Pediatrics
  • Practice Management
  • Pregnancy and Birth
  • Sexual Health
  • Sexually Transmitted Infections
  • Surgery
  • Technology
  • Urology
  • Uterine Fibroids
  • Vulvovaginal Disease
  • Well Woman
Advertisement

Richard H. Lee, MD

Advertisement

Articles by Richard H. Lee, MD

Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic Cholestasis of Pregnancy

ByThe Society for Maternal-Fetal Medicine (SMFM),Richard H. Lee, MD,Mara Greenberg, MD,Torri D. Metz, MD,Christian M. Pettker, MD
June 8th 2021

Intrahepatic cholestasis of pregnancy (ICP) occurs in the second and third trimesters of pregnancy and is characterized by pruritus and elevated serum bile acid concentrations.

Advertisement

Latest Updated Articles

  • Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic Cholestasis of Pregnancy
    Society for Maternal-Fetal Medicine Consult Series #53: Intrahepatic Cholestasis of Pregnancy

    June 8th 2021



Advertisement
Advertisement

Trending on Contemporary OB/GYN

1

IMS: Fezolinetant's improvements in sleep quality, hot flashes as early as week 4

2

Top headlines in women's health from September 2026

3

Wen Shen, MD, on recognizing perimenopause as a window for healthy aging

4

FDA grants priority review to elinzanetant for VMS in women receiving endocrine therapy for breast cancer

5

Contemporary OB/GYN's top expert interviews from September 2026

  • Advertise
  • Contact Us
  • Job Board
  • Terms of Use
  • Privacy Policy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Contagion Live
  • CGT Live
  • Neurology Live
  • HCP Live
  • Oncology Live
  • Contemporary Pediatrics
  • Contemporary OBGYN
  • Urology Times
  • The Educated Patient
  • Patient Care Online
HCP Live Network
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us